Insider and congress filings

Boston Scientific Corporation (BSX)

NYSE · Healthcare · 304 insider filings · 171 congress trades · last filed 7 days agoS&P 500

10
Open-market insider filings shown
2d
Median delay on the insider filings
within the two business day rule
10/0
Purchases and sales in the filings shown

About Boston Scientific Corporation

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Devices
Chief executive
Michael F. Mahoney
Employees
59,000
Listed since
May 19, 1992
Market value
$66.8B
Price to earnings
18.1
Earnings per share
$2.48
Dividend yield
-

www.bostonscientific.com

Earnings

6 reported quarters · next on Oct 28, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 29, 2026$0.86$0.83$5.4B$5.4BEPS beatRevenue in line
Apr 22, 2026$0.80$0.79$5.2B$5.2BEPS beatRevenue in line
Feb 4, 2026$0.80$0.78$5.3B$5.3BEPS beatRevenue in line
Oct 22, 2025$0.75$0.71$5.1B$5.0BEPS beatRevenue beat
Q2 FY2025reported Jul 23, 2025$0.75$0.72$5.1B$4.9BEPS beatRevenue beat
Q1 FY2025reported Apr 23, 2025$0.75$0.67$4.7B$4.6BEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Mar 18, 2026
ExecutiveSalaryStock awardsOtherTotal
Michael F. MahoneyChairman of the Board, President and Chief Executive O$1.4M$13.6M$8.5M$23.5M
Joseph M. FitzgeraldExecutive Vice President and Group President, Cardiova$893K$4.3M$2.8M$8.0M
Arthur C. ButcherExecutive Vice President and Group President, MedSurg $745K$3.4M$2.3M$6.5M
Jonathan R. MonsonExecutive Vice President and Chief Financial Officer$592K$1.6M$3.9M$6.1M
Jeffrey B. MirvissExecutive Vice President and President, Peripheral Int$702K$2.0M$1.5M$4.2M
Vance R. BrownSenior Vice President, General Counsel and Corporate S$659K$1.7M$1.5M$3.9M

The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$5.5B129,680,916-1.6%8.78%
Vanguard Capital Management LLC$4.1B97,087,553+0.7%6.57%
State Street Corp$3.0B70,111,196+3.1%4.74%
Primecap Management Co$2.2B50,520,914+55.3%3.42%
FMR LLC$2.0B45,702,845-38.4%3.09%
Massachusetts Financial Services Co$1.5B24,859,191+126.1%1.68%
Geode Capital Management, LLC$1.4B33,440,102+0.5%2.26%
Vanguard Portfolio Management LLC$1.3B29,792,794-0.0%2.02%
D. E. Shaw & Co., Inc.$1.1B25,457,409+4.7%1.72%
Jpmorgan Chase & Co$1.0B23,907,838-28.3%1.62%
Arrowstreet Capital, Limited Partnership$994.2M23,293,913+67.7%1.58%
Norges Bank$903.5M21,170,029+100.0%1.43%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next BSX filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

10 filings of 304 on record
InsiderActionSharesPriceValueTrade dateDelay
Susan E. MoranoDirectorBought2,040$49.22$100KAug 25, 20261d
David C. HabigerDirectorBought2,100$47.59$100KAug 5, 20262d
David C. HabigerDirectorBought140$48.59$7KAug 4, 20261d
David C. HabigerDirectorBought1,042$48.07$50KAug 3, 20262d
Michael F. MahoneyChairman, President & CEOBought186,240$48.33$9.0MAug 3, 20262d
Edward J. LudwigDirectorBought5,000$45.48$227KJul 31, 20263d
Cheryl PegusDirectorBought1,770$56.49$100KMay 20, 20261d
Edward J. LudwigDirectorBought3,580$56.68$203KMay 20, 20261d
David C. HabigerDirectorBought2,250$55.92$126KMay 20, 20261d
David C. HabigerDirectorBought2,200$56.95$125KMay 19, 20262d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Congress trades in BSX

20 disclosures of 171 on record · median 27d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockPurchase$1,001 - $15,000-7.2%S&P +0.6% · vs S&P 500 -7.8%Aug 3, 2026Sep 4, 202632d
Ro KhannaStockPurchase$1,001 - $15,000-10.9%S&P -1.4% · vs S&P 500 -9.5%Aug 10, 2026Sep 4, 202625d
Ro KhannaStockPurchase$1,001 - $15,000+2.7%S&P +2.7% · vs S&P 500 0.0%Jul 20, 2026Aug 7, 202618d
Ro KhannaStockSale$1,001 - $15,000-0.7%S&P +2.0% · vs S&P 500 -2.8%Jul 7, 2026Aug 7, 202631d
Alan ArmstrongSelfFiled lateStockPurchase$1,001 - $15,000-35.0%S&P +20.2% · vs S&P 500 -55.2%Mar 27, 2026Jul 21, 2026116d
John BoozmanJointStockSale (Partial)$1,001 - $15,000-8.0%S&P +0.7% · vs S&P 500 -8.6%Jun 4, 2026Jul 13, 202639d
Ro KhannaStockSale$1,001 - $15,000-4.2%S&P +1.6% · vs S&P 500 -5.8%Jun 16, 2026Jul 6, 202620d
Ro KhannaStockPurchase$1,001 - $15,000-5.7%S&P +0.4% · vs S&P 500 -6.1%Jun 2, 2026Jul 6, 202634d
Ro KhannaStockPurchase$1,001 - $15,000+5.3%S&P +2.1% · vs S&P 500 +3.3%Jun 30, 2026Jul 6, 20266d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000-7.4%S&P +3.4% · vs S&P 500 -10.8%Jun 5, 2026Jul 2, 202627d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-7.4%S&P +3.4% · vs S&P 500 -10.8%Jun 5, 2026Jul 2, 202627d
Ro KhannaStockPurchase$1,001 - $15,000-14.6%S&P +3.2% · vs S&P 500 -17.8%May 15, 2026Jun 9, 202625d
Ro KhannaStockSale$15,001 - $50,000-20.4%S&P +5.8% · vs S&P 500 -26.2%May 1, 2026Jun 9, 202639d
Ro KhannaStockSale$1,001 - $15,000-10.9%S&P +1.6% · vs S&P 500 -12.5%May 27, 2026Jun 9, 202613d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000-20.9%S&P +3.9% · vs S&P 500 -24.7%May 19, 2026Jun 8, 202620d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000-15.8%S&P +3.1% · vs S&P 500 -18.9%May 11, 2026Jun 8, 202628d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000-6.9%S&P +0.8% · vs S&P 500 -7.7%May 29, 2026Jun 8, 202610d
Ro KhannaStockPurchase$1,001 - $15,000-27.6%S&P +6.8% · vs S&P 500 -34.3%Apr 24, 2026May 11, 202617d
Ro KhannaStockSale$1,001 - $15,000-28.8%S&P +11.6% · vs S&P 500 -40.4%Apr 13, 2026May 11, 202628d
Ro KhannaStockPurchase$15,001 - $50,000-28.6%S&P +20.7% · vs S&P 500 -49.2%Mar 30, 2026Apr 7, 20268d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

8 members · estimate, as of Sep 10, 2026

8 members report a position (estimated). The largest estimated position is in the $250,001 - $500,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Kevin HernRepublican · House$250,001 - $500,0000.9%
Gilbert Ray Cisneros, Jr.Democrat · House$100,001 - $250,0000.3%
Markwayne MullinRepublican · Senate$50,001 - $100,0000.2%
Julie JohnsonDemocrat · House$15,001 - $50,0000.1%
Robert BresnahanRepublican · House$15,001 - $50,0000.1%
Tina SmithDemocrat · Senate$1,001 - $15,0000.2%
Harriet M. HagemanRepublican · House$1,001 - $15,0000.1%
Michael A. RulliRepublican · House$1,001 - $15,0000.4%

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Awards, option exercises and gifts (20)
InsiderEventSharesDate
Padraig Andrew O'ConnorEVP, Global OperationsOption exercise1,171Sep 2, 2026
Padraig Andrew O'ConnorEVP, Global OperationsTax withholding567Sep 2, 2026
Emily WoodworthSVP, Global Controller and CAODiscretionary transaction2,930Aug 11, 2026
Jonathan MonsonEVP and CFODiscretionary transaction9,908Aug 10, 2026
Michael F. MahoneyChairman, President & CEODiscretionary transaction22,119Aug 3, 2026
Joseph Michael FitzgeraldEVP & Group Pres, CardiologyDiscretionary transaction64,198Jul 31, 2026
Jonathan MonsonEVP and CFOOption exercise2,087Jul 1, 2026
Jonathan MonsonEVP and CFOTax withholding1,010Jul 1, 2026
Michael F. MahoneyChairman, President & CEOGift386,755May 28, 2026
Ellen M. ZaneDirectorStock award3,800May 7, 2026
David S. WichmannDirectorStock award3,800May 7, 2026
Christophe Pierre WeberDirectorStock award5,567May 7, 2026
Cathy R. SmithDirectorStock award6,009May 7, 2026
Cheryl PegusDirectorStock award5,081May 7, 2026
Susan E. MoranoDirectorStock award5,081May 7, 2026
Jessica L. MegaDirectorStock award3,800May 7, 2026
Edward J. LudwigDirectorStock award3,800May 7, 2026
David C. HabigerDirectorStock award3,800May 7, 2026
Padraig Andrew O'ConnorEVP, Global OperationsOption exercise1,802May 2, 2026
Padraig Andrew O'ConnorEVP, Global OperationsTax withholding872May 2, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling BSX?

Across the 10 most recent open-market filings shown here, 10 were purchases and 0 were sales.

Which members of Congress have traded BSX?

Ro Khanna, Alan Armstrong, John Boozman, Gilbert Ray Cisneros, Jr. disclosed BSX transactions in the filings shown here.

Which members of Congress hold BSX?

8 members of Congress report a position in BSX in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Kevin Hern, Gilbert Ray Cisneros, Jr. and Markwayne Mullin. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is BSX in the S&P 500 or the Nasdaq 100?

Boston Scientific Corporation is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.

How quickly are BSX trades disclosed?

Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 27 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track